Veterinary Urinalysis Market Size, Share and Trends 2026 to 2035

Veterinary Urinalysis Market (By Product Type: Analyzers, Reagents, Test Strips; By Animal Type: Pets, Livestock, Others; By Application: Kidney Disease, Urinary Tract Infections (UTI), Diabetes Mellitus, Liver Disease, Others; By End-Use: Veterinary Clinics, Animal Hospitals, Research Institutes, Others) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 14 Apr 2026  |  Report Code : 8299  |  Category : Healthcare   |  Format : PDF / PPT / Excel   |  Author : Deepa Pandey   | Reviewed By : Aditi Shivarkar
Revenue, 2025
USD 1.10 Bn
Forecast Year, 2035
USD 2.05 Bn
CAGR, 2026 - 2035
6.40%
Report Coverage
Global

What is the Veterinary Urinalysis Market Size in 2026?

The global veterinary urinalysis market size accounted for USD 1.10 billion in 2025 and is predicted to increase from USD 1.17 billion in 2026 to approximately USD 2.05 billion by 2035, expanding at a CAGR of 6.40% from 2026 to 2035. The market growth is attributed to the rising adoption of preventive animal healthcare and advancements in veterinary urinalysis technologies.

Veterinary Urinalysis Market Size 2026 to 2035

Key Takeaways

  • North America dominated the veterinary urinalysis market with a 40% share in 2025.
  • Asia Pacific is expected to grow at the fastest CAGR of 8.5% between 2026 and 2035.
  • By product type, the analyzers segment held the largest market share of 45% in 2025.
  • By product type, the reagents segment held a 35% share of the market in 2025 and is expected to grow at a significant CAGR of 6.8% between 2026 and 2035.
  • By animal type, the pets segment held a major market share of 60% in 2025.
  • By animal type, the livestock segment held a 35% market share in 2025 and is expected to grow at a 6.8% CAGR during the forecast period.
  • By application, the kidney disease segment contributed the highest market share of 40% in 2025.
  • By application, the urinary tract infections (UTI) segment held a 25% market share in 2025 and is estimated to grow at a strong CAGR of 6.0% over the projected period.
  • By end-use, the veterinary clinics segment contributed the highest market share of 55% in 2025.
  • By end-use, the animal hospitals segment held a 25% share of the market in 2025 and is expected to grow at a significant CAGR of 6.5% between 2026 and 2035.

Market Overview

Rising emphasis on preventive animal healthcare and early disease detection is strongly driving growth in the veterinary urinalysis market. Veterinary urinalysis is a diagnostic method of evaluating the urine by using test strips, analyzers, and microscopy to identify renal and urinary diseases . This technology helps veterinarians to diagnose diseases at an early stage, thus enhancing treatment results. Furthermore, the increase in veterinary infrastructure, along with the need for early detection of diseases, is expected to fuel the market in the coming years.

Impact of Artificial Intelligence on the Veterinary Urinalysis Market

Artificial intelligence is revolutionizing the veterinary urinalysis market by improving accuracy and clinical decision-making in veterinary practices. AI analyzes the results of urine strips and images of sediments with very high accuracy. This improves uniformity in the detection of infections and metabolic diseases. Furthermore, companies including IDEXX Laboratories and Zoetis are combining AI with cloud-based solutions that enable the seamless storage of data and sophisticated analytics.

  • Shift Toward Point-of-Care Diagnostics: Veterinarians are quickly moving toward decentralized testing, making it possible to detect a disease in real-time in clinics and farms. This is creating a robust demand for portable urinalysis gadgets for companion and livestock animals.
  • Integration of Molecular and Multimodal Diagnostics Platforms: Urinalysis is becoming a major part of larger diagnostic panels in molecular, biochemical, and immunological tests. This is enhancing urinalysis from an individual test to an integrative diagnostic procedure.
  • Increasing Pet Insurance Penetration: Rising coverage adoption is fueling higher diagnostic spending, encouraging routine urinalysis testing across insured companion animals.
  • Development of Compact Multi-Test Diagnostic Platforms: Integration of multiple tests into single devices is driving convenience, growing demand for urinalysis-enabled systems.

Market Scope

Report Coverage Details
Market Size in 2025 USD 1.10 Billion
Market Size in 2026 USD 1.17 Billion
Market Size by 2035 USD 2.05 Billion
Market Growth Rate from 2026 to 2035 CAGR of 6.40%
Dominating Region North America
Fastest Growing Region Asia Pacific
Base Year 2025
Forecast Period 2026 to 2035
Segments Covered Product Type, Animal Type, Application, End-Use, and Region
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market Dynamics

Drivers

Increasing Adoption of Preventive Animal Healthcare Practices

Increasing adoption of preventive animal healthcare practices is expected to drive the veterinary urinalysis market. Pet owners are focusing on routine health check-ups, leading to increased frequency of testing as part of annual and biannual visits. This tendency is boosting the use of urinalysis as the front-line diagnostic method in the routine veterinary practice. Furthermore, the spurring demand for livestock health management and productivity optimization is expected to boost urinalysis adoption in production animals.

Restraint

High Cost of Advanced Diagnostic Equipment

High cost associated with advanced diagnostic equipment is expected to hamper the growth of the veterinary urinalysis market. Independent practices face a burden in equipment and recurring costs for maintaining the equipment and reagents. This significantly limits the adoption of advanced urinalysis solutions, especially in price-sensitive markets.

Opportunity

Technological Advancements

Ongoing technological advancements in diagnostic equipment are projected to create immense opportunities for the players competing in the market. Advancements in analyzers and other consumables are enhancing diagnostic accuracy and broadening accessibility of urinalysis solutions. Additionally, veterinary clinics and healthcare organizations are investing in compact and easy-to-use equipment to ensure POC testing.

Segment Insights

Product Type Insights

Veterinary Urinalysis Market Share, By Product Type, 2025-2035 (%)

Product Type 2025 2035 CAGR (%)
Analyzers 45.00% 43.00% 6.50%
Reagents 35.00% 33.00% 6.80%
Test Strips 20.00% 24.00% 7.00%

The Analyzers Segment Dominated the Market With a 40% Share in 2025

The analyzers segment dominated the veterinary urinalysis market with a major share of 40% in 2025. This is because of their crucial role in improving efficiency and eliminating manual errors in urine testing. Modern analyzer systems offer accurate measurements of vital parameters. They enhance the reliability of diagnostics in complex conditions, including renal ailments and infections. Furthermore, the increasing demand for standardized diagnostic protocols with the growing networks of veterinarians further boosts the segment growth in the coming years.

Veterinary Urinalysis Market Share, By Product Type, 2025-2035 (%)

The reagents segment held the second-largest market share of 35% in 2025 and is expected to grow at a significant CAGR of 6.8% between 2026 and 2035. This is mainly due to the growing demand for proper and consistent urinalysis results on every testing platform. The growing use of automated diagnostic solutions propels the need for compatible reagent kits that are designed to be used with integrated systems. Moreover, reagents are essential for accurate analysis, driving their adoption.

The test strips segment held a 20% share of the market in 2025 and is expected to grow at the fastest CAGR of 7% during the projection period. This is due to their universal application in fast and affordable diagnostic screening. Test strips are becoming more popular due to their ease of use, cost-effectiveness, and quick results for common veterinary conditions. Furthermore, the rising awareness of the importance of using a rapid screening tool is expected to boost the demand for test strips.

Animal Type Insights

Veterinary Urinalysis Market Share, By Animal Type, 2025-2035 (%)

Animal Type 2025 2035 CAGR (%)
Pets 60.00% 58.00% 6.50%
Livestock 35.00% 37.00% 6.80%
Others 5.00% 5.00% 5.00%

Why Did the Pets Segment Dominated the Market in 2025?

The pets segment dominated the veterinary urinalysis market with the largest share of 60% in 2025. This is mainly due to a significant rise in the number of diagnostic procedures being performed on companion animals. Preventive care packages have increased in urban veterinary practices, which incorporate urinalysis as a routine diagnostic element. With the rapid increase in pet ownership, especially dogs and cats, and growing awareness of pet health, the demand for veterinary urinalysis in pets has increased over the years.

Veterinary Urinalysis Market Share, By Animal Type, 2025-2035 (%)

The livestock segment was the second-largest shareholder in 2025, holding a 35% share, and is expected to grow at a strong CAGR of 6.8% over the projection period. This is primarily due to the increasing need for health monitoring of production animals. The adoption of urinalysis is part of herd health management programs to enhance disease control and reproductive efficiency. Moreover, the livestock health management is becoming a crucial aspect of sustainable agriculture systems, thus propelling the demand for veterinary urinalysis.

Application Insights

The Kidney Disease Segment Led the Market With a 40% Share in 2025

The kidney diseases segment dominated the veterinary urinalysis market with a share of 40% in 2025, driven by the strong reliance on urinalysis for early detection of renal disorders. The rising population of aging pets and increasing prevalence of chronic conditions have made kidney screening a routine part of veterinary care. Clinical findings indicate that nearly 30-40% of cats over 10 years old show signs of kidney dysfunction during screenings. Additionally, the growing use of routine urinalysis for renal monitoring continues to strengthen the diagnosis and management of kidney diseases in veterinary practice, supporting segmental growth.

The urinary tract infections (UTI) segment held a 25% share of the market in 2025 and is expected to grow at a strong CAGR of 6% over the projected period. This is because of the high incidence of UTIs in pets. UTIs are common in pets, especially cats and dogs. Urinalysis is a commonly used diagnostic procedure for UTI, as it is a low-cost, rapid, and simple test for detecting infections.

Veterinary Urinalysis Market Share, By Application, 2025-2035 (%)

Application 2025 2035 CAGR (%)
Kidney Disease 40.00% 42.00% 7.50%
Urinary Tract Infections (UTI) 25.00% 24.00% 6.00%
Diabetes Mellitus 15.00% 16.00% 8.00%
Liver Disease 10.00% 9.00% 5.50%
Others 10.00% 9.00% 5.00%

The diabetes mellitus segment held a 15% share of the market in 2025 and is expected to grow at the fastest CAGR of 8% between 2026 and 2035. This growth is driven by rising obesity rates in pets, which is increasing the risk of diabetes. As a result, veterinary clinics are increasingly incorporating routine urinalysis into diabetes management protocols to monitor disease progression and support ongoing treatment decisions.

The liver disease segment held a 10% share of the market in 2025 and is expected to register a significant CAGR of 5.5% during the forecast period. This growth is supported by the use of urinalysis in detecting bilirubin and other biomarkers associated with liver dysfunction. Veterinary professionals rely on urine testing as a key diagnostic tool to assess liver health and monitor the progression of liver-related diseases.

End-Use Insights

The Veterinary Clinics Segment Dominated the Market With a 55% Share in 2025

The veterinary clinics segment dominated the veterinary urinalysis market with a major share of 55% in 2025, driven by their central role in routine diagnostics and primary animal healthcare services. Urinalysis has increasingly become a standard component of preventive wellness checkups, often included in routine care packages offered by clinics. Additionally, the expansion of corporate veterinary clinic chains across urban and semi-urban regions has further strengthened the adoption of urinalysis technologies, driving overall market growth.

Veterinary Urinalysis Market Share, By End-Use, 2025-2035 (%)

End-Use 2025 2035 CAGR (%)
Veterinary Clinics 55.00% 53.00% 6.20%
Animal Hospitals 25.00% 24.00% 6.50%
Research Institutes 10.00% 10.00% 6.00%
Others 10.00% 13.00% 7.50%

The animal hospitals segment held a 25% share of the market in 2025 and is expected to grow at a significant CAGR of 6.5% between 2026 and 2035. This is mainly due to their crucial role in handling complex and specialized veterinary cases. These are facilities that deal with critical conditions that involve intensive diagnostic assessment, such as advanced urinalysis tests.

The research institutions segment held a 10% share of the market in 2025 and is expected to grow at a 6% CAGR in the upcoming period. This growth is driven by increased funding in veterinary research and development, along with expanding studies focused on early disease detection and diagnostic accuracy. These efforts are strengthening the role of research institutions in advancing veterinary urinalysis technologies and applications.

Regional Insights

North America Veterinary Urinalysis Market Size and Growth 2026 to 2035

The North America veterinary urinalysis market size is estimated at USD 440.00 million in 2025 and is projected to reach approximately USD 830.25 million by 2035, with a 6.56% CAGR from 2026 to 2035.

North America Veterinary Urinalysis Market Size 2025 to 2035

North America Dominated the Market in 2025

North America led the veterinary urinalysis market, capturing the largest revenue share of 40% in 2025, driven by strong adoption of advanced veterinary diagnostic systems. High pet ownership rates in the region further support demand for routine screening and early disease detection services. Approximately 66% of U.S. households own pets, reinforcing the need for comprehensive animal healthcare. Additionally, growing preference for specialized diagnostics and integrated pet health management solutions is expected to further drive market growth in the region.

U.S. Veterinary Urinalysis Market Size and Growth 2026 to 2035

The U.S. veterinary urinalysis market size is calculated at USD 330.00 million in 2025 and is expected to reach nearly USD 626.84 million in 2035, accelerating at a strong CAGR of 6.63% between 2026 and 2035.

U.S. Veterinary Urinalysis Market Size 2025 to 2035

U.S. Market Analysis

U.S. leads the market within North America, driven by its advanced veterinary infrastructure and high adoption of diagnostic testing . Diagnostic companies are increasingly introducing AI-enabled analyzers and connected systems, improving operational efficiency and supporting more accurate clinical decision-making. As a result, the country continues to hold a dominant share in the region, driven by its strong advancement in veterinary diagnostics and growing demand for high-quality animal healthcare services.

Veterinary Urinalysis Market Share, By Region, 2025-2035 (%)

Europe: The Second-Largest Market

Europe is the second-largest market, holding a 25% share of the market in 2025, and is estimated to grow at a strong CAGR of 6.5% over the projected period. This growth is driven by its well-established veterinary healthcare system and increasing emphasis on standardized diagnostic practices. Organizations such as the Federation of Veterinarians of Europe are promoting routine screening and preventive care. In addition, rising awareness of companion animal health is further boosting demand for veterinary urinalysis services across the region.

Germany Market Analysis

In Germany, the market is driven by rising awareness of animal health among pet owners, leading to increased veterinary visits and higher diagnostic testing volumes. Veterinary professionals are placing greater emphasis on preventive screening and early diagnosis, resulting in wider adoption of urinalysis across clinics and laboratories.

How is the Opportunistic Rise of Asia Pacific in the Veterinary Urinalysis Market?

Asia Pacific held a 20% share of the market in 2025 and is expected to grow at the fastest CAGR of 8.5% between 2026 and 2035. This growth is driven by increasing adoption of veterinary diagnostics in emerging economies. Rising pet ownership across countries such as China, India, and Southeast Asia is also driving the market. Moreover, demand for routine diagnostic testing is expanding rapidly, further supporting the growth of the veterinary urinalysis market in the region.

China Market Analysis

China is a major contributor to the market within Asia Pacific, supported by rapid urbanization and increasing pet ownership. The expansion of veterinary healthcare services is improving access to diagnostic tools such as urinalysis, particularly in urban areas. Additionally, the adoption of advanced diagnostic equipment in veterinary clinics is increasing to meet the growing demand for preventive animal healthcare.

Veterinary Urinalysis Market Companies

  • Abaxis, Inc . (now part of Zoetis)
  • Alpha Diagnostics
  • Arkray, Inc.
  • Biochemical Diagnostics Inc.
  • DRE Veterinary
  • Elanco Animal Health Incorporated
  • F. Hoffmann-La Roche Ltd.
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Mindray Medical International Ltd.
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • VCA Inc. (part of Mars Petcare)
  • Virbac
  • Zoetis Inc.

Recent Developments

  • In April 2026, Sysmex Europe introduced the UC-1100 semi-automated urine chemistry analyzer, designed to enhance flexibility in routine urinalysis workflows across laboratories, clinics, and near-patient settings. The system features a compact design, intuitive interface, and improved connectivity, allowing seamless integration into existing diagnostic environments.(Source: https://www.sysmex.no )
  • In February 2026, Bionote USA launched the Vcheck U urinalysis analyzer, combining urine chemistry and sediment analysis within a single platform for canine and feline diagnostics. The system processes samples in approximately four minutes, evaluating 15 chemistry and 16 sediment parameters. This supports the detection of metabolic disorders, kidney conditions, infections, and urolithiasis.(Source: https://www.bionote.com )
  • In January 2024, Zoetis Inc. expanded its Vetscan Imagyst diagnostics platform with a new AI-powered urine sediment analysis feature. The solution uses deep learning AI to deliver fast, in-clinic urine analysis within minutes, enabling veterinarians to make quicker and more accurate treatment decisions. This enhancement strengthens real-time diagnostic capabilities and supports improved, individualized care for pets, particularly dogs and cats.(Source: https://news.zoetis.com )

Segments Covered in the Report

By Product Type

  • Analyzers
  • Reagents
  • Test Strips

By Animal Type

  • Pets
    • Dogs
    • Cats
  • Livestock
    • Cattle
    • Sheep
    • Goats
  • Others

By Application

  • Kidney Disease
  • Urinary Tract Infections (UTI)
  • Diabetes Mellitus
  • Liver Disease
  • Others

By End-Use

  • Veterinary Clinics
  • Animal Hospitals
  • Research Institutes
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia-pacific
  • Middle and East Africa

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The veterinary urinalysis market size is expected to increase from USD 1.10 billion in 2025 to USD 2.05 billion by 2035.

Answer : The veterinary urinalysis market is expected to grow at a compound annual growth rate (CAGR) of around 6.40% from 2026 to 2035.

Answer : The major players in the veterinary urinalysis market include Abaxis, Inc. (now part of Zoetis), Alpha Diagnostics, Arkray, Inc., Biochemical Diagnostics Inc., DRE Veterinary, Elanco Animal Health Incorporated, F. Hoffmann-La Roche Ltd., Heska Corporation, IDEXX Laboratories, Inc., Mindray Medical International Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., VCA Inc. (part of Mars Petcare), Virbac, and Zoetis Inc.

Answer : The driving factors of the veterinary urinalysis market are the rising adoption of preventive animal healthcare and advancements in veterinary urinalysis technologies.

Answer : North America region will lead the global veterinary urinalysis market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Deepa Pandey

Deepa Pandey

Author

Deepa Pandey is the principal consultant in the precedence research, with 2+ years of experience in the market research industry.With a Master’s in Pharmacy specializing in Pharmaceutical Quality Assurance, Deepa Pandey brings a unique combination of scientific knowledge and market research expertise to Precedence Research. She plays a critical role in shaping the content and analysis that define the firm’s research reports. Over the past five years, Deepa has contributed to over 70 reports, providing clients with clear, actionable insights into the healthcare and pharmaceutical industries. Her deep understanding of regulatory requirements, quality processes, and operational dynamics allows her to translate complex information into practical strategies for global stakeholders.

Read more about Deepa Pandey
Aditi Shivarkar

Aditi Shivarkar

Reviewed By

Aditi brings more than 14 years of experience to Precedence Research, serving as the driving force behind the accuracy, clarity, and relevance of all research content. She reviews every piece of data and insight to ensure it meets the highest quality standards, supporting clients in making informed decisions. Her expertise spans healthcare, ICT, automotive, and diverse cross-industry domains, allowing her to provide nuanced perspectives on complex market trends. Aditi’s commitment to precision and analytical rigor makes her an indispensable leader in the research process.

Learn more about Aditi Shivarkar

Related Reports